Individuals Who Use ViolencePARTS-IPV RCTNCT07747766
Program for Alleviating Relationship Trauma and Stress for Intimate Partner Violence - Randomized Control Trial
A study testing Program For Alleviating Relationship Trauma and Stress through New Behaviors and DVIT Treatment As Usual (TAU) in people with Individuals Who Use Violence and Interpersonal Violence, run by Cambridge Health Alliance at 2 sites in United States.
Trial summary
This research study investigates the feasibility of a randomized control trial of a group-based treatment program for reducing stress, trauma, substance use, and use of violence among individuals who were court-mandated to attend a program after committing an act(s) of domestic violence. Read more about this study
- Who is it for?
- Ages 18 years and older, men only
- Conditions the study is for
- Individuals Who Use Violence, Interpersonal Violence
- What is being tested?
- Program For Alleviating Relationship Trauma and Stress through New Behaviors and DVIT Treatment As Usual (TAU)
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 48 participants
- Where
- 2 sitesUnited States
- Study dates
- 1 Aug 2026to 31 Jul 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Must be male-identifying or prefer to be in a male-identifying group;
- Must be a resident of Washington state;
- Must be court-referred to a treatment program for using violence with an intimate partner;
- Have sufficient English fluency and literacy skills to understand the consent process, procedures and questionnaires and have the ability to provide written informed consent;
- Have access to the internet and an electronic device with adequate data capacity; to complete questionnaires online and attend online video conference groups;
- Must be available and willing to attend at least 17 out of 20 scheduled online group sessions; and
- Must be available and willing to complete the online computerized assessments, and phone interviews.
Who cannot join
- Insufficiently stable housing or internet connection to be able to join at least 17 group sessions;
- Current participation in another experimental research study;
- Expected medical hospitalization in the next six months from study enrollment period;
- Current or expected physical incarceration (excluding house arrest or other forms of electronic monitoring) in the next six months from study enrollment period;
- Inpatient hospitalization for mental health, substance use, suicide attempt or self-harm within past three months;
- Inability to participate safely in the study intervention and without disrupting the group (in the opinion of principal investigator OR meeting any of the following criteria)
Show all 14Show fewer
- Past year history of a psychotic disorder or clinician confirmed active psychosis assessed by the Structured Clinical Interview for DSM-5 (SCID-5);
- Bipolar I disorder history or current severe level of mania assessed by the Structured Clinical Interview for DSM-5 (SCID-5);
- Acute suicidality with intent will be excluded from the study (Structured Clinical Interview for DSM-5 [SCID-5]);
- High levels of Psychopathy as defined by self-report psychopathy checklist (SRP-4);
- Self-injurious behavior in past three months will require clinical assessment prior to participation in the program;
- Acute homicidality with plan and/or intent;
- Inability to join a group without intoxication.
- Prior experience or exposure with Internal Family Systems (e.g. IFS therapy, IFS groups or retreats, current IFS practice, etc.)
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
United States2 sites
Cambridge Health Alliance Center for Mindfulness and Compassion
Malden, Massachusetts, 02148
Zev Schuman-Olivier, MD, 617-591-6056, zschuman@cha.harvard.edu
Waterland Counseling
Tumwater, Washington, 98512
Valerie Waterland, 360-234-3259, valerie@waterlandservice.com
About this study
This research study investigates the feasibility of a randomized control trial of a group-based treatment program for reducing stress, trauma, substance use, and use of violence among individuals who were court-mandated to attend a program after committing an act(s) of domestic violence. The study is in a 2-arm design with an intervention group and a control group.
Read the detailed description
We previously tested a pilot program called PARTS-NB (Program For Alleviating Relationship Trauma and Stress- New Behaviors), an adaptation of the original PARTS Program and a study registered under the name of PARTS IPV (NCT06765122). The pilot program included unique and specific elements for People who Use Violence (PUV) in intimate relationships. Preliminary results from the PARTS IPV pilot suggest that intervention-based feasibility was met, with a total of 13 individuals attending at least 1 group and 12/13 individuals attending at least 8/12 of the first 12 groups. Mean acceptability was 26 (SD =3.4) meeting the acceptability criteria for the intervention at week 12. Moreover, individuals in the pilot PARTS IPV had overall declines in their aggression scales, minor psychological aggression (CTS2) and trended towards lower values and less variance in severe psychological aggression (CTS2). Interestingly, we also observed reductions in the frequency of individuals having six or more drinks (Question 3, AuditC).
Given these results, this project is an important and timely study with high-quality pilot randomized control clinical trial design. The methodology aligns closely with the specific aims described in this application and uses several innovative features and some carefully implemented gold-standard measures to ensure a high likelihood of success and publication. This will be the first RCT testing an intensive model of IFS group therapy designed specifically for those who use violence within intimate partner relationships with concurrent intermittent individual meetings for ongoing evaluation and support.
Previous reviews of interventions suggest there is a gap in effective interventions to treat IPV for those with trauma backgrounds (Cheng et al., 2021; Travers et al. 2021). PARTS1, PARTS2 and PARTS for Substance Use Disorder (PARTS SUD) have all demonstrated enhanced emotion regulation and self-related processing (Comeau et al. 2024; Ally et al. 2025; Joss et al. 2026). The protocol's methodology follows previous intimate partner violence studies, incorporating verbal consent and partner inclusion, while employing rigorously implemented informed consent procedures and gold-standard measures to enhance the likelihood of success and publication. While CBT IPV interventions vary in length (e.g., Strength at Home (SAH) groups are 12-weeks, standard state programs such as the psychoeducation program in the State of Washington are 26 sessions), we will use a phased approach that will run a total of 20 weeks with 20 group sessions and 6-9 individual sessions.
Primary Aims The primary aim of this study is to conduct a NIH Stage III hybrid "real-world implementation" study assessing the feasibility and acceptability (Nathan, 2007; Onken et al., 2014) of an Internal Family Systems intensive group program (Program for Alleviating and Reducing Trauma and Stress - IPV) (PARTS-IPV Phase 2) versus domestic violence treatment intervention treatment as usual (DVIT-TAU) control group on individuals mandated for treatment. We have two primary aims for this pilot RCT protocol: feasibility and acceptability.
Feasibility is defined in two ways: intervention-based feasibility: in both arms, we expect 70% of participants completing at least 67% (e.g., 8/12) of the first 12 groups. For study-protocol feasibility we do not expect differences in the arms but expect each arm to obtain overall 67% or more of participants completing week-20 study assessments (H1.1).
Secondary Aims H2.1: A secondary aim is overall acceptability of the intervention as measured by the Client Satisfaction Questionnaire (CSQ-8) (Larsen et al., 1979) where for both arms, we expect a mean score of at least 20 out of a total of 32 (H2.1).
H2.2: Intervention satisfaction, as measured by a satisfaction question (would you recommend a friend) will obtain at least a mean of 7 out of 10 (H2.2) in week 20 for both arms.
H2.3: Another secondary aim of the study is to investigate the potential effects of the intervention on the Revised Conflict Tactics Scale (CTS2) (Straus et al., 1996; Chapman \& Gillespie, 2019) and Multidimensional Measure of Emotional Abuse- Restrictive Engulfment (MMEA-RE Subscale) (Murphy \& Hoover, 1999). We hypothesize a risk reduction in physical and psychological violence from self-reports in both arms IFS/DVIT-TAU arm (H2.3). In our pilot (N=12), baseline mean of the psychological aggression subscale was 0.51 (SD=0.17), indicating that some participants had very high aggression scores while others did not. In Week 12, the mean was 0.13 (SD=0.12), suggesting that everyone clustered near zero, with a reduction in variability and suggesting a potential for stabilization in risk. Risk reduction in this case is both improvement and stabilization (decreased or stable scores).
For this pilot RCT, we hypothesize a greater risk reduction (decreased/stable scores) of psychological aggression use in the IFS arm compared to DVIT-TAU as measured by the psychological aggression subscale in CTS2 and MMEA-RE Subscale (H2.3).
H2.4: Lastly, in the pilot, we observed declines in the Aggression Experience Sampler (AES) from baseline to week 12. Average baseline scores were 13.97 (SE=0.63) with weekly rates of decline of -0.06 (p-value=0.09), indicating decreases ranging from 0.01 to 0.13 points per week. Based on these pilot findings we hypothesize that the 20-week RCT intervention will produce a weekly decline of -0.04 in AES scores (H2.4).
Exploratory Aims Exploratory outcomes include effects on mechanisms of emotion regulation, decentering, self-critical rumination, and self-compassion.
We hypothesize a greater capacity for decentering (Experiences Questionnaire - Decentering subscale (EQ)), reductions in self-critical rumination, reactivity in interpersonal relationships (OAS2, IRI-SF), as well as an increase in emotion identification and regulation (PAQ-S, Difficulties in Emotion Regulation Scale (DERS)), transcendent experiences (NADA-Bliss subscale), and self-compassion (using Self-Compassion Scale Short Form (SCS-SF)) self report, in IFS PARTS compared to DVIT-TAU at week 12 and 20. Other exploratory aims of the study are to investigate the effects of the intervention on general mental health including posttraumatic stress disorder, depression, anxiety (Achtyes et al., 2015; Guinart et al., 2021), and substance use (Craving Scale, AUDIT-C).
- Being tested
- Program For Alleviating Relationship Trauma and Stress through New Behaviors, DVIT Treatment As Usual (TAU)
- Keywords
- Interpersonal Violence, Domestic Violence, Internal Family Systems (IFS), Program For Alleviating Relationship Trauma and Stress (PARTS)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Program For Alleviating Relationship Trauma and Stress through New BehaviorsBehavioural
Also called Program For Alleviating Relationship Trauma and Stress - InterPersonal Violence
The experiential protocol includes 15 minutes of themed curriculum and 45 minutes of experiential exercises, e.g., going inside meditation, centering practice, witnessing their own parts, psychodrama, speaking for parts exercises, finding parts in the body, etc. In addition, participants will have 30 minutes to speak in the group about their experience and review the manual focused on new coping strategies and behaviors. We will ask participants to keep a journal to write down observations and parts they notice during the week and ask them to bring the journal and manual we send to them to the group so they can record information they remember after exercises.
All participants also will be scheduled to have approximately six to nine standard clinical one-hour sessions with an individual IFS trained counselor (at least Level 1 IFS trained) during their time in the program, with an average of one-two sessions per month (6-9 total individual sessions).
DVIT Treatment As Usual (TAU)Behavioural
Treatment As Usual (TAU) for people who use violence in interpersonal and domestic relationships. In WA state currently, these treatments are usually a mix of elements from Cognitive Behavioral Therapy (CBT), Duluth Model, and/or Moral Reconation Therapy (MRT). Participants in this group will not be exposed to IFS during TAU, to preserve the integrity of the study design. The number of individual counseling sessions during TAU will be tracked, but it can vary based on need in the treatment as usual modalities.
| Study group | Role | What they receive |
|---|---|---|
| PARTS-NB Arm | Experimental | Participants (N=24 anticipated) randomly allocated to this arm with undergo an IFS-based intervention called PARTS-NB, which curriculum is adapted from the original PARTS program and encompasses a mix of weekly group sessions (120 minutes each) for 20 weeks and individual IFS therapy sessions (minimum 6, and up to 9). Receives: Behavioral: Program For Alleviating Relationship Trauma and Stress through New Behaviors |
| DVIT-TAU Arm | Active comparator | The control group (N=24 anticipated) will follow Treatment As Usual (TAU) for people who use violence in interpersonal and domestic relationships. Currently in WA state, these treatments are a mix of elements from Cognitive Behavioral Therapy (CBT), Duluth Model, and/or Moral Reconation Therapy (MRT). Participants in this group will not be exposed to IFS during TAU to preserve the integrity of the study design. The number of individual counseling sessions during TAU will be tracked, but it can vary based on need in the treatment as usual modalities. Receives: Behavioral: DVIT Treatment As Usual (TAU) |
What is being measured
The primary outcome is the main question the study is designed to answer.
H1.1 - Intervention Feasibility
70% of participants attend 67% of group sessions Study feasibility: 70% of participants complete of post study assessments For study-protocol feasibility we do not expect differences in the arms but expect each arm to obtain overall 67% or more of participants completing week-20 study assessments (H1.1)
Measured: From enrollment to the end of treatment at 20 weeks
Secondary outcomes (4)
H2.1. - Acceptability
Mean score of 20 on the Client Satisfaction Questionnaire (CSQ-8) general acceptability item A secondary aim is overall acceptability of the intervention as measured by the Client Satisfaction Questionnaire (CSQ-8) (Larsen et al., 1979) where for both arms, we expect a mean score of at least 20 out of a total of 32 (H2.1)
Measured: From enrollment to the end of treatment at 20 weeks
H2.2 -- Satisfaction
Intervention satisfaction, as measured by a satisfaction question (would you recommend a friend) will obtain at least a mean of 7 out of 10 (H2.2) in week 20 for both arms Mean >7.0 of 10 on willingness to refer a friend on Satisfaction Questionnaire
Measured: From enrollment to the end of treatment at 20 weeks
H2.3 -- Conflict Tactics
Investigate the potential effects of the intervention on the Revised Conflict Tactics Scale (CTS2) (Straus et al., 1996; Chapman \& Gillespie, 2019) and Multidimensional Measure of Emotional Abuse- Restrictive Engulfment (MMEA-RE Subscale) (Murphy \& Hoover, 1999). We hypothesize a risk reduction in physical and psychological violence from self-reports in both arms IFS/DVIT-TAU arm (H2.3). In our pilot (N=12), baseline mean of the psychological aggression subscale was 0.51 (SD=0.17), indicating that some participants had very high aggression scores while others did not. In Week 12, the mean was 0.13 (SD=0.12), suggesting that everyone clustered near zero, with a reduction in variability and suggesting a potential for stabilization in risk. Risk reduction in this case is both improvement and stabilization (decreased or stable scores).
Measured: From enrollment to the end of treatment at 20 weeks
H2.4 -- Aggression Experience
in the pilot PARTS IPV study, we observed declines in the Aggression Experience Sampler (AES) from baseline to week 12. Average baseline scores were 13.97 (SE=0.63) with weekly rates of decline of -0.06 (p-value=0.09), indicating decreases ranging from 0.01 to 0.13 points per week. Based on these pilot findings we hypothesize that the 20-week RCT intervention will produce a weekly decline of -0.04 in AES scores (H2.4)
Measured: From enrollment to the end of treatment at 20 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Aug 2026
- Study start1 Aug 2026 (estimated)
- Primary completion31 Jul 2027 (estimated)
- Study completion31 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Individuals Who Use ViolenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This study is a Stage 1 behavioral therapy trial (different than a NIH Phase trial for FDA approval), a randomized clinical trial investigating the "real-world" feasibility and acceptability of the PARTS IPV program group intervention vs. the DVIT-TAU control intervention on those mandated for treatment of use of violence in intimate partnerships.
- Masking
- None (open label)
- Enrolment
- 48 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cambridge Health Alliance
- Sponsor type
- University, hospital or other
- Collaborators
- Waterland Counseling Services, Washington State Department of Commerce Office of Crime Victims Advocacy
- Responsible party
- Principal investigator, Zev Schuman Olivier, Cambridge Health Alliance
- Investigators
- Zev Schuman-Olivier, MD, Principal investigator, Center for Mindfulness & Compassion - Cambridge Health Alliance
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07747766
- Sponsor's protocol ID
- CHA-IRB-24-25-422
- Acronym
- PARTS-IPV RCT
- Status last verified
- Jul 2026
- First submitted
- 31 Jul 2026
- Last updated
- 5 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Tobiasz Veltz, L. (2025). Efficacy of an Online, Group-Based Internal Family Systems (IFS) Intervention on PTSD Symptom Clusters. ProQuest Dissertations & Theses.
Ally D, Tobiasz-Veltz L, Tu K, Comeau A, Bumpus C, Blot T, Rice FK, Orr B, Soumerai Rea H, Sweezy M, Schuman-Olivier Z. A pilot study of an online group-based Internal Family Systems intervention for comorbid posttraumatic stress disorder and substance use. Front Psychiatry. 2025 Mar 27;16:1544435. doi: 10.3389/fpsyt.2025.1544435. eCollection 2025.
PubMed 40212833Comeau A, Smith LJ, Smith L, Soumerai Rea H, Ward MC, Creedon TB, Sweezy M, Rosenberg LG, Schuman-Olivier Z. Online group-based internal family systems treatment for posttraumatic stress disorder: Feasibility and acceptability of the program for alleviating and resolving trauma and stress. Psychol Trauma. 2024 Dec;16(Suppl 3):S636-S640. doi: 10.1037/tra0001688. Epub 2024 Jun 27.
PubMed 38934934Taft CT, Franz MR, Cole HE, D'Avanzato C, Rothman EF. Examining strength at home for preventing intimate partner violence in civilians. J Fam Psychol. 2021 Sep;35(6):857-862. doi: 10.1037/fam0000732. Epub 2021 Mar 18.
PubMed 33734765Joss D, Comeau A, Chevannes R, Parry G, Rea HS, Barria J, Bumpus C, Rector A, Rajan A, Rosansky J, Rice FK, Ward MC, Tobiasz Veltz L, Ally D, Rosenberg LG, Sweezy M, Lovas D, Schuman-Olivier Z. A randomized controlled trial of an online group-based internal family systems treatment for posttraumatic stress disorder: The Program for Alleviating and Resolving Trauma and Stress (PARTS) study. Psychol Trauma. 2026 Jan 29. doi: 10.1037/tra0002089. Online ahead of print.
PubMed 41609644
Study at a glance
From the registry record, last updated by the sponsor on 5 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Program for Alleviating Relationship Trauma and Stress for Intimate Partner Violence - Randomized Control Trial
- ClinicalTrials.gov ID
- NCT07747766
- Acronym / sponsor ID
- PARTS-IPV RCT / CHA-IRB-24-25-422
- Keywords
- Interpersonal Violence, Domestic Violence, Internal Family Systems (IFS), Program For Alleviating Relationship Trauma and Stress (PARTS)
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 48 participants (estimated)
- Lead sponsor
- Cambridge Health AllianceUniversity, hospital or other
- Collaborators
- Waterland Counseling Services, Washington State Department of Commerce Office of Crime Victims Advocacy
- Study start
- 1 Aug 2026 (estimated)
- Primary completion
- 31 Jul 2027 (estimated)
- Study completion
- 31 Jul 2027 (estimated)
- First posted
- 5 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This research study investigates the feasibility of a randomized control trial of a group-based treatment program for reducing stress, trauma, substance use, and use of violence among individuals who were court-mandated to attend a program after committing an act(s) of domestic violence. The study is in a 2-arm design with an intervention group and a control group.
Detailed description
We previously tested a pilot program called PARTS-NB (Program For Alleviating Relationship Trauma and Stress- New Behaviors), an adaptation of the original PARTS Program and a study registered under the name of PARTS IPV (NCT06765122). The pilot program included unique and specific elements for People who Use Violence (PUV) in intimate relationships. Preliminary results from the PARTS IPV pilot suggest that intervention-based feasibility was met, with a total of 13 individuals attending at least 1 group and 12/13 individuals attending at least 8/12 of the first 12 groups. Mean acceptability was 26 (SD =3.4) meeting the acceptability criteria for the intervention at week 12. Moreover, individuals in the pilot PARTS IPV had overall declines in their aggression scales, minor psychological aggression (CTS2) and trended towards lower values and less variance in severe psychological aggression (CTS2). Interestingly, we also observed reductions in the frequency of individuals having six or more drinks (Question 3, AuditC).
Given these results, this project is an important and timely study with high-quality pilot randomized control clinical trial design. The methodology aligns closely with the specific aims described in this application and uses several innovative features and some carefully implemented gold-standard measures to ensure a high likelihood of success and publication. This will be the first RCT testing an intensive model of IFS group therapy designed specifically for those who use violence within intimate partner relationships with concurrent intermittent individual meetings for ongoing evaluation and support.
Previous reviews of interventions suggest there is a gap in effective interventions to treat IPV for those with trauma backgrounds (Cheng et al., 2021; Travers et al. 2021). PARTS1, PARTS2 and PARTS for Substance Use Disorder (PARTS SUD) have all demonstrated enhanced emotion regulation and self-related processing (Comeau et al. 2024; Ally et al. 2025; Joss et al. 2026). The protocol's methodology follows previous intimate partner violence studies, incorporating verbal consent and partner inclusion, while employing rigorously implemented informed consent procedures and gold-standard measures to enhance the likelihood of success and publication. While CBT IPV interventions vary in length (e.g., Strength at Home (SAH) groups are 12-weeks, standard state programs such as the psychoeducation program in the State of Washington are 26 sessions), we will use a phased approach that will run a total of 20 weeks with 20 group sessions and 6-9 individual sessions.
Primary Aims The primary aim of this study is to conduct a NIH Stage III hybrid "real-world implementation" study assessing the feasibility and acceptability (Nathan, 2007; Onken et al., 2014) of an Internal Family Systems intensive group program (Program for Alleviating and Reducing Trauma and Stress - IPV) (PARTS-IPV Phase 2) versus domestic violence treatment intervention treatment as usual (DVIT-TAU) control group on individuals mandated for treatment. We have two primary aims for this pilot RCT protocol: feasibility and acceptability.
Feasibility is defined in two ways: intervention-based feasibility: in both arms, we expect 70% of participants completing at least 67% (e.g., 8/12) of the first 12 groups. For study-protocol feasibility we do not expect differences in the arms but expect each arm to obtain overall 67% or more of participants completing week-20 study assessments (H1.1).
Secondary Aims H2.1: A secondary aim is overall acceptability of the intervention as measured by the Client Satisfaction Questionnaire (CSQ-8) (Larsen et al., 1979) where for both arms, we expect a mean score of at least 20 out of a total of 32 (H2.1).
H2.2: Intervention satisfaction, as measured by a satisfaction question (would you recommend a friend) will obtain at least a mean of 7 out of 10 (H2.2) in week 20 for both arms.
H2.3: Another secondary aim of the study is to investigate the potential effects of the intervention on the Revised Conflict Tactics Scale (CTS2) (Straus et al., 1996; Chapman \& Gillespie, 2019) and Multidimensional Measure of Emotional Abuse- Restrictive Engulfment (MMEA-RE Subscale) (Murphy \& Hoover, 1999). We hypothesize a risk reduction in physical and psychological violence from self-reports in both arms IFS/DVIT-TAU arm (H2.3). In our pilot (N=12), baseline mean of the psychological aggression subscale was 0.51 (SD=0.17), indicating that some participants had very high aggression scores while others did not. In Week 12, the mean was 0.13 (SD=0.12), suggesting that everyone clustered near zero, with a reduction in variability and suggesting a potential for stabilization in risk. Risk reduction in this case is both improvement and stabilization (decreased or stable scores).
For this pilot RCT, we hypothesize a greater risk reduction (decreased/stable scores) of psychological aggression use in the IFS arm compared to DVIT-TAU as measured by the psychological aggression subscale in CTS2 and MMEA-RE Subscale (H2.3).
H2.4: Lastly, in the pilot, we observed declines in the Aggression Experience Sampler (AES) from baseline to week 12. Average baseline scores were 13.97 (SE=0.63) with weekly rates of decline of -0.06 (p-value=0.09), indicating decreases ranging from 0.01 to 0.13 points per week. Based on these pilot findings we hypothesize that the 20-week RCT intervention will produce a weekly decline of -0.04 in AES scores (H2.4).
Exploratory Aims Exploratory outcomes include effects on mechanisms of emotion regulation, decentering, self-critical rumination, and self-compassion.
We hypothesize a greater capacity for decentering (Experiences Questionnaire - Decentering subscale (EQ)), reductions in self-critical rumination, reactivity in interpersonal relationships (OAS2, IRI-SF), as well as an increase in emotion identification and regulation (PAQ-S, Difficulties in Emotion Regulation Scale (DERS)), transcendent experiences (NADA-Bliss subscale), and self-compassion (using Self-Compassion Scale Short Form (SCS-SF)) self report, in IFS PARTS compared to DVIT-TAU at week 12 and 20. Other exploratory aims of the study are to investigate the effects of the intervention on general mental health including posttraumatic stress disorder, depression, anxiety (Achtyes et al., 2015; Guinart et al., 2021), and substance use (Craving Scale, AUDIT-C).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- This study is a Stage 1 behavioral therapy trial (different than a NIH Phase trial for FDA approval), a randomized clinical trial investigating the "real-world" feasibility and acceptability of the PARTS IPV program group intervention vs. the DVIT-TAU control intervention on those mandated for treatment of use of violence in intimate partnerships.
| Arm | Type | Receives |
|---|---|---|
| PARTS-NB Arm | Experimental | Behavioral: Program For Alleviating Relationship Trauma and Stress through New BehaviorsParticipants (N=24 anticipated) randomly allocated to this arm with undergo an IFS-based intervention called PARTS-NB, which curriculum is adapted from the original PARTS program and encompasses a mix of weekly group sessions (120 minutes each) for 20 weeks and individual IFS therapy sessions (minimum 6, and up to 9). |
| DVIT-TAU Arm | Active comparator | Behavioral: DVIT Treatment As Usual (TAU)The control group (N=24 anticipated) will follow Treatment As Usual (TAU) for people who use violence in interpersonal and domestic relationships. Currently in WA state, these treatments are a mix of elements from Cognitive Behavioral Therapy (CBT), Duluth Model, and/or Moral Reconation Therapy (MRT). Participants in this group will not be exposed to IFS during TAU to preserve the integrity of the study design. The number of individual counseling sessions during TAU will be tracked, but it can vary based on need in the treatment as usual modalities. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Must be male-identifying or prefer to be in a male-identifying group;
- Must be a resident of Washington state;
- Must be court-referred to a treatment program for using violence with an intimate partner;
- Have sufficient English fluency and literacy skills to understand the consent process, procedures and questionnaires and have the ability to provide written informed consent;
- Have access to the internet and an electronic device with adequate data capacity; to complete questionnaires online and attend online video conference groups;
Key exclusion criteria (14 listed)
- Insufficiently stable housing or internet connection to be able to join at least 17 group sessions;
- Current participation in another experimental research study;
- Expected medical hospitalization in the next six months from study enrollment period;
- Current or expected physical incarceration (excluding house arrest or other forms of electronic monitoring) in the next six months from study enrollment period;
- Inpatient hospitalization for mental health, substance use, suicide attempt or self-harm within past three months;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Program For Alleviating Relationship Trauma and Stress through New BehaviorsAlso: Program For Alleviating Relationship Trauma and Stress - InterPersonal ViolenceThe experiential protocol includes 15 minutes of themed curriculum and 45 minutes of experiential exercises, e.g., going inside meditation, centering practice, witnessing their own parts, psychodrama, speaking for parts exercises, finding parts in the body, etc. In addition, participants will have 30 minutes to speak in the group about their experience and review the manual focused on new coping strategies and behaviors. We will ask participants to keep a journal to write down observations and parts they notice during the week and ask them to bring the journal and manual we send to them to the group so they can record information they remember after exercises. All participants also will be scheduled to have approximately six to nine standard clinical one-hour sessions with an individual IFS trained counselor (at least Level 1 IFS trained) during their time in the program, with an average of one-two sessions per month (6-9 total individual sessions). | Behavioural | PARTS-NB Arm |
| DVIT Treatment As Usual (TAU)Treatment As Usual (TAU) for people who use violence in interpersonal and domestic relationships. In WA state currently, these treatments are usually a mix of elements from Cognitive Behavioral Therapy (CBT), Duluth Model, and/or Moral Reconation Therapy (MRT). Participants in this group will not be exposed to IFS during TAU, to preserve the integrity of the study design. The number of individual counseling sessions during TAU will be tracked, but it can vary based on need in the treatment as usual modalities. | Behavioural | DVIT-TAU Arm |
Primary outcome
H1.1 - Intervention Feasibility
Time frame: From enrollment to the end of treatment at 20 weeks
70% of participants attend 67% of group sessions Study feasibility: 70% of participants complete of post study assessments For study-protocol feasibility we do not expect differences in the arms but expect each arm to obtain overall 67% or more of participants completing week-20 study assessments (H1.1)
4 secondary outcomes
H2.1. - Acceptability
Time frame: From enrollment to the end of treatment at 20 weeks
H2.2 -- Satisfaction
Time frame: From enrollment to the end of treatment at 20 weeks
H2.3 -- Conflict Tactics
Time frame: From enrollment to the end of treatment at 20 weeks
H2.4 -- Aggression Experience
Time frame: From enrollment to the end of treatment at 20 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Aug 2026.
- BackgroundTobiasz Veltz, L. (2025). Efficacy of an Online, Group-Based Internal Family Systems (IFS) Intervention on PTSD Symptom Clusters. ProQuest Dissertations & Theses.
- Background: PubMed 40212833Ally D, Tobiasz-Veltz L, Tu K, Comeau A, Bumpus C, Blot T, Rice FK, Orr B, Soumerai Rea H, Sweezy M, Schuman-Olivier Z. A pilot study of an online group-based Internal Family Systems intervention for comorbid posttraumatic stress disorder and substance use. Front Psychiatry. 2025 Mar 27;16:1544435. doi: 10.3389/fpsyt.2025.1544435. eCollection 2025.
- Background: PubMed 38934934Comeau A, Smith LJ, Smith L, Soumerai Rea H, Ward MC, Creedon TB, Sweezy M, Rosenberg LG, Schuman-Olivier Z. Online group-based internal family systems treatment for posttraumatic stress disorder: Feasibility and acceptability of the program for alleviating and resolving trauma and stress. Psychol Trauma. 2024 Dec;16(Suppl 3):S636-S640. doi: 10.1037/tra0001688. Epub 2024 Jun 27.
- Background: PubMed 33734765Taft CT, Franz MR, Cole HE, D'Avanzato C, Rothman EF. Examining strength at home for preventing intimate partner violence in civilians. J Fam Psychol. 2021 Sep;35(6):857-862. doi: 10.1037/fam0000732. Epub 2021 Mar 18.
- Background: PubMed 41609644Joss D, Comeau A, Chevannes R, Parry G, Rea HS, Barria J, Bumpus C, Rector A, Rajan A, Rosansky J, Rice FK, Ward MC, Tobiasz Veltz L, Ally D, Rosenberg LG, Sweezy M, Lovas D, Schuman-Olivier Z. A randomized controlled trial of an online group-based internal family systems treatment for posttraumatic stress disorder: The Program for Alleviating and Resolving Trauma and Stress (PARTS) study. Psychol Trauma. 2026 Jan 29. doi: 10.1037/tra0002089. Online ahead of print.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Zev Schuman-Olivier, MD principal investigator
Center for Mindfulness & Compassion - Cambridge Health Alliance
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Program For Alleviating Relationship Trauma and Stress through New Behaviors and DVIT Treatment As Usual (TAU) in people with Individuals Who Use Violence and Interpersonal Violence, run by Cambridge Health Alliance at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 5 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Laure Tobiasz Veltz, ALM, MBA, MS (617-806-8735, ltobiaszveltz@challiance.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
H1.1 - Intervention Feasibility (time frame: From enrollment to the end of treatment at 20 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07747766, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2026.